Skip to main content
Xlife Sciences AG logo

Xlife Sciences AG — Investor Relations & Filings

Ticker · XLS ISIN · CH0461929603 LEI · 984500AH590BE88BB517 SW Professional, scientific and technical activities
Open in API
Filings indexed 287 across all filing types
Latest filing 2021-07-02 Director's Dealing
Country CH Switzerland
Listing SW XLS

About Xlife Sciences AG

https://www.xlifesciences.ch/en/home

Xlife Sciences AG is a life sciences company that specializes in the value development and commercialization of early-stage research projects. The company identifies promising technologies from universities and other research institutions, acting as an incubator and accelerator to bridge the gap between academic research and healthcare markets. Its operations are focused on four core areas: technology platforms, biotechnologies and therapies, medical technology (health technology), and the application of artificial intelligence in life sciences and digital health. The primary objective is to develop solutions that address high unmet medical needs and improve quality of life.

Recent filings

Filing Released Lang Actions
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Oliver R. Baumann), their position ('Member of the managing body'), and records a specific transaction (Acquisition of shares) with price, volume, and date. This content directly matches the definition for Director's Dealing.
2021-07-02 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document explicitly uses the header "Directors’ Dealings" and the regulatory phrase "Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them." This directly corresponds to the definition of Director's Dealing reports. The content details the transaction (Acquisition), the person involved (Oliver R. Baumann, Member of the managing body), the instrument (Share), and the date/price. This maps precisely to the 'DIRS' filing type code.
2021-07-02 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction (Acquisition) by a person discharging managerial responsibilities (Oliver R. Baumann, Member of the managing body) in the company's shares. This directly matches the definition for Director's Dealing (DIRS). The structure and content are typical of insider transaction disclosures.
2021-07-02 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document explicitly uses the header "Directors’ Dealings" and the regulatory disclosure title "Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them". This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS. The content details the transaction (Acquisition) by a member of the managing body (Oliver R. Baumann). The document length is short (2171 chars), but the content is the primary disclosure itself, not an announcement of a report, making DIRS the correct classification.
2021-07-02 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document explicitly uses the header "Directors’ Dealings" and contains detailed information regarding a transaction by a person discharging managerial responsibilities (Oliver R. Baumann, Member of the managing body). Section 4 details the nature of the transaction ('Acquisition'), the financial instrument ('Share'), price, volume, and date. This content directly matches the definition for Director's Dealing.
2021-07-02 English
DGAP-DD: Xlife Sciences AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. Section 4 details the 'transaction(s)' including the nature ('Acquisition'), price, volume, and date. This content directly matches the definition for Director's Dealing (DIRS). The document length is short (2170 chars), but the content is the primary disclosure itself, not an announcement of a separate report.
2021-07-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.